A single dose of psilocybin in a controlled setting appears to reap long-term benefits
Hallucinogens are back on the table—at least when it comes to clinical trials. Hundreds of trials in the 1940s and 1950s studied their effects, but since their ban in the late '60s the research all but stopped, reports the New York Times
. Nowadays, though, drugs like MDMA (think...